Exact Sciences finds that where there’s muck there’s brass, but specialisation does not work as well for Abiomed.
GE sells its Biopharma business for $21.4bn, but is its IPO cancelled or merely on hold?
Big medtech is keeping its purse-strings closed – but private equity sees value in subsidiaries.
Big cap medtech is hiring, largely thanks to organic growth.
GE arrives to the spin-out party fashionably late.
Siemens cuts down the size of its Healthineers spin-off partly thanks to market volatility, but still hopes to create a nimbler company.
Intuitive Surgical is the winner in terms of sales per employee, despite increasing its headcount 17%.